William F. Rencher - Oct 19, 2021 Form 3/A - Amendment Insider Report for Context Therapeutics Inc. (CNTX)

Role
Head of CMC and Regulatory
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Oct 19, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
12/17/2021, 03:08 PM
Date Of Original Report
Oct 19, 2021
Next filing
Feb 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTX Stock Option (right to buy) Oct 19, 2021 Common Stock 416 $20.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested

Remarks:

These additional options were omitted from the reporting person's original Form 3 on October 19, 2021.